Live Analyst Rating Changes 1348 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Jonathan Hughes
RJ
Jonathan Hughes
Wall Street Analyst
★★★★☆
#611
on 13Foresight · ranked by our own returns
75%
Success Rate
+9.6%
Average Return
12 of 16 calls profitable · -9.4% vs benchmark
🔒 5-year track record is Pro. Showing 1-year — upgrade.
📈 Across the calls we could measure, roughly 75% of Jonathan Hughes's ratings turned a profit when each position was held for 1 year — averaging +9.6% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

10 Buy 0 Hold 1 Sell
Jonathan's Stock Coverage 17 ratings · 2026-06-18
Company Date Position Consensus Price Target 1-Yr Return
DOC
Healthpeak Properties
Sep 15, 2025 BUY Buy
+18.4% avg upside
42 analysts
$20.00
3.04% Upside
+19.5%
HR
Healthcare Realty Trust
Sep 15, 2025 SELL Buy
+7.9% avg upside
23 analysts
-18.2%
CTRE
CareTrust REIT
Sep 02, 2025 BUY Strong Buy
-0.1% avg upside
22 analysts
$39.00
7.25% Upside
+24.5%
OHI
Omega Healthcare
Sep 02, 2025 BUY Buy
-3.5% avg upside
29 analysts
$46.00
3.13% Upside
+12.3%
WELL
Welltower
Sep 02, 2025 BUY Strong Buy
-11.8% avg upside
32 analysts
$195.00
5.65% Downside
+24.5%
VTR
Ventas
Aug 22, 2025 BUY Strong Buy
-0.1% avg upside
34 analysts
$78.00
5.04% Downside
+25.5%
SMA
SmartStop Self Storage REIT, Inc.
Aug 18, 2025 BUY Strong Buy
+13.8% avg upside
9 analysts
$42.00
31.72% Upside
-10.9%
EXR
Extra Space Storage
Aug 11, 2025 BUY Buy
+3.5% avg upside
30 analysts
$160.00
11.17% Upside
+15.0%
CUBE
Cubesmart
Aug 11, 2025 BUY Buy
+3.8% avg upside
26 analysts
$45.00
12.31% Upside
+8.1%
PSA
Public Storage
Aug 11, 2025 BUY Buy
-0.8% avg upside
29 analysts
$350.00
12.06% Upside
+16.4%
COLD
Americold Realty
May 13, 2025 BUY Buy
+29.7% avg upside
23 analysts
$25.00
76.61% Upside
-9.7%
STAG
Stag Industrial
May 07, 2025 BUY Buy
+1.8% avg upside
26 analysts
$38.00
2.02% Upside
+20.1%
EGP
Eastgroup Properties
May 07, 2025 BUY Strong Buy
+0.4% avg upside
31 analysts
$200.00
1.26% Upside
+27.8%
PLD
Prologis
Feb 03, 2025 HOLD Strong Buy
+3.0% avg upside
32 analysts
+15.9%
MPT
Medical Properties Trust
Dec 16, 2024 SELL Hold
+154.0% avg upside
24 analysts
·
DHC
Diversified Healthcare Trust
Jan 07, 2020 HOLD Hold
+24.4% avg upside
11 analysts
-44.9%
SBRA
Sabra Healthcare REIT
Nov 16, 2018 HOLD Buy
+7.1% avg upside
28 analysts
$24.00
32.88% Upside
+28.4%
🔒 12 more ratings — with price targets, crowd consensus and our measured returns.
Free account unlocks every analyst's full coverage table.
Jonathan Hughes — Frequently Asked Questions
How accurate are Jonathan Hughes's stock ratings?
Based on the calls 13Foresight could measure, about 75% of Jonathan's ratings were profitable over a one-year hold, with an average return of +9.6% per rating, or -9.4% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Jonathan ranked on 13Foresight?
Jonathan Hughes is currently ranked #611 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Jonathan cover?
Jonathan most recently has ratings on DOC, HR, CTRE, OHI, WELL, VTR, SMA, EXR, CUBE, PSA, COLD, STAG and 5 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.